Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration.
Cappelli LV, Meggendorfer M, Baer C, Nadarajah N, Hutter S, Jeromin S, Dicker F, Kern W, Haferlach T, Haferlach C, Höllein A.
Cappelli LV, et al. Among authors: haferlach t, haferlach c.
Leukemia. 2022 Feb;36(2):394-402. doi: 10.1038/s41375-021-01368-1. Epub 2021 Aug 10.
Leukemia. 2022.
PMID: 34376804
Free PMC article.